Saturday 2 November 2024

The tobacco settlement will cost Ottawa $5 billion in lost tax revenue (and much more in health impact)

 The federal government seemingly had a very minor role in the mediation between tobacco companies and the provincial governments that were suing them to recovery health care costs. That may prove to be a problem. 

The proposed plan that has emerged from these discussions - and that will be subject to a creditors' vote on December 12 - suggests that the federal (and national) interests may have been compromised by this deal that was brokered in secret over the past 5 years. 

This post identifies the financial downsides to the federal government from this deal. A future post will look at the public health implications.

Next year, Revenue Canada is set to issue $1.8+ billion in settlement-related tax refunds (and will lose $150 million per year for the subsequent 20 years)

Over the past 5+ years, the companies have been required to preserve all of their income and to set it aside to resolve their debts. The $12.5 billion that has been amassed so far will be used to provide upfront damage payments to class actions and provinces. Over the next 20 or so years, the remaining $20 billion of the damages promised will be paid in annual installments.

The cash reserve was built from the after-tax income of the tobacco companies. Now that this "income" is being converted into "damages", the corporate income tax of the companies will be reassessed and the income tax paid in those years will be refunded. This expectation is clearly identified in the settlement, and is several times referred to as "Tax Refund Cash Payment".

Based on a federal corporate income tax rate of 15%, the amount refunded by the federal government for the upfront damage payments of $12.45 billion will be in the order of $1.8 billion. The cost to the federal treasury for the remaining $20 billion will be $3 billion: with an annual loss of $150 million if the repayment rate follows that forecast by the plan. The total cost to the federal treasury will thus be around $4.8 billion.

Corporate income tax paid to provinces will also be refundable. Because their tax rates are lower, the refund will be smaller. Presuming a provincial corporate income tax rate of 10%, this will reduce the real value of the settlement payments to the provinces by 10%, or $2.47 billion.

From the perspective of Canadian citizens - who are implicated in the finances of both federal and provincial governments - the true value of the settlement payments is diluted by the impact on both provincial and federal corporate income tax revenues. 

The true value to the collective public purse of the provincial settlements is thus reduced by these tax implications from $24.725 billion to $18.54 billion. Once payments to outside counsel, discussed here earlier, are also factored in, the true value falls by a further $1.77 billion, to $16.77 billion.  Lost income taxes and legal fees thus reduce the societal value of the settlement by one-third.

Revenue Canada is owed hundreds of millions - the Plan does not provide for repayment 

When Imperial Tobacco applied for creditor protection in March 2019, it identified a debt to Canada Customs and Revenue Agency of more than $500 million.  When the vote is taken on December 12, this debt to the government of Canada is reduced (without explanation) to $333,535,110.  There is no provision in the proposed plan for this amount to be repaid to the federal government. Justice Morawetz commented on this during the hearing on October 31st, noting that there may be other provisions in law which apply to amounts owing to government.

If this debt is not repaid, the federal government will be out of pocket by more than a decade's value of the yet-to-be-implemented Tobacco Cost Recovery Framework. 

Ottawa will help pay for the continued smoking that is built into the settlement

The federal government provides a significant portion of the health care costs for which the provincial governments sought recovery. Yet there is no indication that the any of the payments made by tobacco companies to the provinces will be shared with federal government, or that Ottawa will be off the hook for its share of the escalating health care costs caused by smoking.

Economist Glenn Harrison was engaged to calculate the costs to provincial health care systems resulting from tobacco use, with separate calculations for tobacco use by people who became addicted before 1996. His report, included as appendix "G" in the proposed plan, provides these estimates for each province in graphical form. 

Mr. Harrison's estimate for Ontario, shown above, suggests that the cost of treating smoking-caused diseases will continue to rise for the next quarter century: with an estimated annual cost of $6 billion in 2030 and $7 billion in 2040. The situation is similar in all provinces. 

Because of the Canada Health Transfer, Ottawa is a stakeholder in provincial health care systems, and is affected by the provisions in the proposed plan to impose a covenant on companies that they will maintain their business practices to ensure the continued sale of cigarettes.

 The federal government seemingly had a very minor role in the mediation between tobacco companies and the provincial governments that were suing them to recovery health care costs. That may prove to be a problem. 

The proposed plan that has emerged from these discussions - and that will be subject to a creditors' vote on December 12 - suggests that the federal (and national) interests may have been compromised by this deal that was brokered in secret over the past 5 years. 

This post identifies the financial downsides to the federal government from this deal. A future post will look at the public health implications.

Next year, Revenue Canada is set to issue $1.8+ billion in settlement-related tax refunds (and will lose $150 million per year for the subsequent 20 years)

Over the past 5+ years, the companies have been required to preserve all of their income and to set it aside to resolve their debts. The $12.5 billion that has been amassed so far will be used to provide upfront damage payments to class actions and provinces. Over the next 20 or so years, the remaining $20 billion of the damages promised will be paid in annual installments.

The cash reserve was built from the after-tax income of the tobacco companies. Now that this "income" is being converted into "damages", the corporate income tax of the companies will be reassessed and the income tax paid in those years will be refunded. This expectation is clearly identified in the settlement, and is several times referred to as "Tax Refund Cash Payment".

Based on a federal corporate income tax rate of 15%, the amount refunded by the federal government for the upfront damage payments of $12.45 billion will be in the order of $1.8 billion. The cost to the federal treasury for the remaining $20 billion will be $3 billion: with an annual loss of $150 million if the repayment rate follows that forecast by the plan. The total cost to the federal treasury will thus be around $4.8 billion.

Corporate income tax paid to provinces will also be refundable. Because their tax rates are lower, the refund will be smaller. Presuming a provincial corporate income tax rate of 10%, this will reduce the real value of the settlement payments to the provinces by 10%, or $2.47 billion.

From the perspective of Canadian citizens - who are implicated in the finances of both federal and provincial governments - the true value of the settlement payments is diluted by the impact on both provincial and federal corporate income tax revenues. 

The true value to the collective public purse of the provincial settlements is thus reduced by these tax implications from $24.725 billion to $18.54 billion. Once payments to outside counsel, discussed here earlier, are also factored in, the true value falls by a further $1.77 billion, to $16.77 billion.  Lost income taxes and legal fees thus reduce the societal value of the settlement by one-third.

Revenue Canada is owed hundreds of millions - the Plan does not provide for repayment 

When Imperial Tobacco applied for creditor protection in March 2019, it identified a debt to Canada Customs and Revenue Agency of more than $500 million.  When the vote is taken on December 12, this debt to the government of Canada is reduced (without explanation) to $333,535,110.  There is no provision in the proposed plan for this amount to be repaid to the federal government. Justice Morawetz commented on this during the hearing on October 31st, noting that there may be other provisions in law which apply to amounts owing to government.

If this debt is not repaid, the federal government will be out of pocket by more than a decade's value of the yet-to-be-implemented Tobacco Cost Recovery Framework. 

Ottawa will help pay for the continued smoking that is built into the settlement

The federal government provides a significant portion of the health care costs for which the provincial governments sought recovery. Yet there is no indication that the any of the payments made by tobacco companies to the provinces will be shared with federal government, or that Ottawa will be off the hook for its share of the escalating health care costs caused by smoking.

Economist Glenn Harrison was engaged to calculate the costs to provincial health care systems resulting from tobacco use, with separate calculations for tobacco use by people who became addicted before 1996. His report, included as appendix "G" in the proposed plan, provides these estimates for each province in graphical form. 

Mr. Harrison's estimate for Ontario, shown above, suggests that the cost of treating smoking-caused diseases will continue to rise for the next quarter century: with an estimated annual cost of $6 billion in 2030 and $7 billion in 2040. The situation is similar in all provinces. 

Because of the Canada Health Transfer, Ottawa is a stakeholder in provincial health care systems, and is affected by the provisions in the proposed plan to impose a covenant on companies that they will maintain their business practices to ensure the continued sale of cigarettes.

As a creditor of Imperial Tobacco, the government of Canada will have 1 vote on December 12th on the version of the plan that would apply to that company.  For the reasons outlined above, there is every financial reason for it to say "no".




Thursday 24 October 2024

The proposed tobacco settlement mandates continued cigarette sales for 20+ years

There are many good reasons to doubt the sincerity of tobacco companies when they say they want to end the sale of combustible cigarettes.   There are no good reason for provincial governments to have included a requirement that they keep selling conventional cigarettes for decades to come.

This post reports on the "covenant" to maintain tobacco sales that is contained in the settlement made public last week

The covenants

Under each of the three individualized forms of the settlement, each company has undertaken to "not conduct their businesses and operations, divest assets, rearrange ownership, and/or alter their corporate structures, and/or operational practices, in any manner that circumvents or is adverse to the ability ...  to satisfy its obligations under the CCAA Plan..."


In short, once this settlement agreement is formally approved by the provinces and by the Ontario court overseeing the insolvency, the companies will be obliged to maintain their tobacco trade with the same enthusiasm and marketing tools that are currently in place. 

Two structural elements of the settlement have led to this condition: (1) the deferral of payments to the provinces over a period of decades and (2) the exclusion of "alternative products" from the terms of the settlement.

Deferred payments 

Most of the money paid to the provinces will come in installments that are spread out over many years. Although $6 billion will be paid from the $12.5 billion in savings that were safeguarded during the years of insolvency protection, the remaining $19 billion in provincial payments will be taken as a percentage of the companies future income on tobacco sales. 

For the first 5 years, the companies will provide 85% of their income, but after every 5 year period the proportion steps down by 5% (Year 6 to 10 at 80%, years 11 to 15 at 75%, etc.) 

Included in the settlement document is a chart ("Estimated Upfront Contribution Available") which forecasts the amount that will be paid in the near future. Between now and 2030, the companies forecast providing about $1 billion per year to the provinces. At that rate, their debt to the provinces will not be met until after 2045.

Because of their covenant, for the next 20-plus years the companies have a legal obligation to maintain current efforts to sell tobacco products

Exclusion of "alternative products"

Payments to the provinces come from tobacco sales, but not from the sale of vaping or heated tobacco products. All "alternative products" are carved out of the CCAA Plan.

To make this exclusion more overt, the companies are required to set up separate companies to manage the sale of these alternative goods. This is largely already the case, in the sense that different corporate structures exist for newer products: for example, Nicoventures is a corporate subsidiary of  BAT. 

“Alternative Product” means (i) any device that produces emissions in the form of an aerosol and is intended to be brought to the mouth for inhalation of the aerosol without burning of (a) a substance; or (b) a mixture of substances; (ii) any substance or mixture of substances, whether or not it contains tobacco or nicotine, that is intended for use with or without those devices to produce emissions in the form of an aerosol without burning; (iii) any non-combustible tobacco (other than smokeless tobacco) or nicotine delivery product; or (iv) any component, part, or accessory of or used in connection with any such device or product referred to above."

The settlement thus provides the companies with an incentive to increase the sales of these newer nicotine products because they can keep all of the revenue. At the same time, they are under an obligation to maintain tobacco sales. The settlement thus puts pressure on the system to increase overall nicotine use. 

Links to each company's proposed agreement and the covenant to maintain tobacco sales. 

Imperial Tobacco:  (British American Tobacco)

ARTICLE 11. COVENANTS AND OTHER PAYMENT ASSURANCE
11.1 Covenants
...

(g) Imperial and its Material Subsidiaries shall conduct their businesses in good faith with a view to fulfilling their obligations pursuant to the Definitive Documents, and shall not conduct their businesses and operations, divest assets, rearrange ownership, and/or alter their corporate structures, and/or operational practices, in any manner that circumvents or is adverse to the ability of Imperial to satisfy its obligations under the CCAA Plan including, the ability of Imperial to pay the Upfront Contributions, Tax Refund Cash Payments and/or Annual Contributions within the Contribution Period; 

JTI-Macdonald  (Japan Tobacco)

ARTICLE 11. COVENANTS AND OTHER PAYMENT ASSURANCE
11.1 Covenants
...

(g) JTIM and its Material Subsidiaries shall conduct their businesses in good faith with a view to fulfilling their obligations pursuant to the Definitive Documents, and shall not conduct their businesses and operations, divest assets, rearrange ownership, and/or alter their corporate structures, and/or operational practices, in any manner that circumvents or is adverse to the ability of JTIM to satisfy its obligations under the CCAA Plan including, the ability of JTIM to pay the Upfront Contributions, Tax Refund Cash Payments and/or Annual Contributions within the Contribution Period; 

Rothmans, Benson & Hedges (Philip Morris)

ARTICLE 11. COVENANTS AND OTHER PAYMENT ASSURANCE
11.1 Covenants
...

(g) RBH and its Material Subsidiaries shall conduct their businesses in good faith with a view to fulfilling their obligations pursuant to the Definitive Documents, and shall not conduct their businesses and operations, divest assets, rearrange ownership, and/or alter their corporate structures, and/or operational practices, in any manner that circumvents or is adverse to the ability of RBH to satisfy its obligations under the CCAA Plan including, the ability of RBH to pay the Upfront Contributions, Tax Refund Cash Payments and/or Annual Contributions within the Contribution Period; 


Tuesday 22 October 2024

A closer look at the claims and payments in the proposed settlement

This post focuses on the amount of compensation that would flow to provincial governments, injured smokers and other parties under the proposed settlement between tobacco companies and those suing for damages.

The figures shown below (and in the downloadable fact sheet) are taken from the version of the settlement that is written with BAT-Imperial Tobacco Canada in mind. 

Two and a half cents on the dollar for provincial governments 

The overall claims of the provinces were not based on their initial court filings, but were established through a bespoke formula provided by a consultant (Dr. Glenn Harrison) and detailed in Schedule "G" to the settlement. The claims of the provinces totalled $944.5 billion, making up 98% of the total claims of $964.1 billion. 

A total of $32.5 billion is provided for in the settlement, representing 3.4% of the total identified claims. Each province will receive 2.6% of the amount of its claim, and the total to be provided to provinces is equal to 76% of the payments. 


Thirty to fifty cents on the dollar for eligible smokers.

Quebec class action victims were awarded $13.7 billion by Quebec courts and will receive $4.12 billion. Ignoring inflation, they will receive 30% of their court award. Their claim represents 1.42% of the total claims and 12.7% of the payments.

The Pan Canadian Claimants (smokers in other parts of Canada) will receive 50% of the calculated equivalent of the amount awarded to Quebec claimants, albeit with different eligibility criteria based on limitation periods. Their claims make up 0.52% of the total claims and 7.8% of the payments

Other payments

Tobacco farmers will receive 51.6% of their claim of $29 million dollars (about 3 hundredths of a percent of the total claims)

A foundation will be created, and $1 billion will be provided for its operations. This represents about 3% of the total compensation.





Monday 21 October 2024

Health voices condemn the provincial tobacco settlements

Late in the day on Thursday, October 17th, a proposed settlement was made public. This settlement would resolve the lawsuits filed by provincial governments, the class action lawsuits filed on behalf of injured smokers and a few other small claims. 

This post reports on the response to the settlement by public health agencies and leaders. 

The terms of the settlement with the provincial government have been widely criticized for their failure to include measures to reduce smoking or to modify the tobacco trade. The portion of the settlement which resolves class action claims has received widespread support.

Representative extracts of media statements and press releases are shown below. 

----------------------------------

Action on Smoking & Health, Physicians for a Smoke-Free Canada, Quebec Coalition for Tobacco Control: Provincial governments have squandered a unique and historic opportunity to put an end to the tobacco industry
Press release, October 17, 2024.

Apart from the compensation to victims or their descendants in Québec and in the rest of Canada, which is the only positive component of this deal, there is little public health benefit to be found in this arrangement. The settlement provides no roadmap aimed at preventing these very same companies from causing more damage by recruiting new victims, including through new enticing nicotine gadgets.

Despite the tobacco industry having its back against the wall, the provinces choose to negotiate themselves a cash windfall without bothering to change the corporate behaviour at the core of the lawsuits. Provinces have deliberately agreed to allow Big Tobacco to maintain its business model extracting profits from addiction and harm in perpetuity. They have shamelessly turned a blind eye to the damage these very same companies will inflict on future generations.

Canadian Cancer Society criticizes proposed tobacco settlement as inadequate
Press release, October 18, 2024

"The approach in the proposed settlement falls massively short and fails to protect the future health of Canadians properly," says Rob Cunningham, lawyer for the Canadian Cancer Society. "How can such an approach possibly be justified when we continue to have millions of Canadians who smoke each year and while tobacco remains the leading cause of cancer death? This settlement fails to support public health efforts to reduce smoking."


The Canadian Lung Association responds to proposed settlement in tobacco lawsuits
Statement, October 18, 2024

We feel that the proposed settlement is not only monetarily insufficient but missing key measures that would prevent the tobacco industry from returning to business as usual.

We urge the government and all parties involved to reconsider this proposed settlement and seek a just outcome that truly addresses the devastating consequences of tobacco-related harm. Canadians have the right to expect a fair and equitable resolution that holds the tobacco industry accountable for its actions and provides adequate compensation for those affected while ensuring that the right supports are in place to protect generations to come.

Campaign for Justice on Tobacco Fraud: Tobacco Settlement Cave In
Press release, October 21, 2024

Tobacco lawyers would argue that the Companies Creditors Arrangement Act exists to ensure the long-term viability of companies that seek protection. We hold that governments ultimately hold all of the cards, legislation, and could have used their muscle in these talks if they had been committed to public health.

"This settlement is an embarrassment," said Mahood. "Other than providing payments to Quebec smokers harmed by the industry and due via a class action court award, the settlement has no redeeming value. It should be abandoned, not the kids who will be harmed by an industry restored to good health."

Michael Chaiton, Senior Scientist, CAMH
City News, October 18, 2024

“The lesson of these lawsuits is that cigarettes … should not be a profitable consumer product and that there are alternatives available, he said."

“Functionally, I think some of the settlement protects the companies to allow them to continue to sell those products in particular, rather than switching over.”

David Hammond, Professor, University of Waterloo
City News, October 18, 2024

"Their business practices essentially haven't changed and won't change," said Hammond.

"The industry still generates billions of profits from cigarettes, and so I think they will continue the practices that have been generating that revenue."

Rob Cunningham, Canadian Cancer Society
CBC News, October 18, 2024

Rob Cunningham, senior policy analyst for the Canadian Cancer Society, says the proposal does not go far enough. He's calling on the provinces to make changes before it's approved.

"This proposed settlement contains nothing to actually reduce smoking," Cunningham said Friday in an interview with CBC News Network.

Cynthia Callard, Physicians for a Smoke-Free Canada
National Post, October 18, 2024

Callard said the provinces could have taken a much different approach to this suit focused on winding down the industry.

“The government had the option to force the companies into bankruptcy and to find an orderly way to wind up down their business and to actually chase out smoking. Instead, they’ve given them carte blanche to operate,” she said.

Callard said she expects the proposed deal will go through. She said while the deal is a disappointment it is also an opportunity for governments to step up and do a better job regulating the industry, both cigarettes and vaping, because they have failed to do so in the past.

“Obviously, the industry did wrong, it hurt people, that’s what they’re settling about. But governments stood back in those years and let the company operate in that inadequately regulated way,” she said.



Thursday 17 October 2024

Provinces, class actions and tobacco companies reach a deal.

This evening a proposed settlement to resolve the many Canadian tobacco lawsuits was made public. The 1437 page draft agreement can be downloaded here

The litigation efforts behind this effort have spanned a generation. The first provincial lawsuit was filed by British Columbia in November 1998 and resubmitted in January 2001). During this time, tobacco companies continued to sell cigarettes, governments continued to collect taxes, and smokers continued to die. 

Over the past 66 months, there has been complete secrecy by the provincial governments in their handling of negotiations with tobacco companies. With the proposed settlement now made public, there is an opportunity for legislators and the public to engage in an assessment of the proposal and to offer guidance to government with respect to the next steps in this process.

In evaluating the proposal, Canadians might consider the following questions:

  • Will this settlement change the behaviour of the tobacco companies? 
  • Does this settlement provide justice to smokers?
  • Are there important and relevant issues which are not resolved by this settlement?

Included in the plan

In brief, the plan proposes that the companies will pay a total of $32.5 billion, of which the amount that has been held in reserve during the insolvency process (about $12.5 billion) will be available after the agreement is approved by court. $20 billion will be provided to provincial governments in deferred payments.

* $24.8 billion will be paid to the provinces, including a deferred payment of about $18 billion. This will settle the claims of over $500 billion filed by the provinces since 2001.  Unlike the U.S. agreements, these payments will be made as a percentage of revenue from tobacco sales, starting with a remittance of 85% of net after tax income from tobacco sales. (The companies will keep all of their revenue from vaping or other products). 

* $6.75 billion will be paid to some smokers who have suffered from lung cancer, throat cancer or emphysema. Of this, $4.25 billion will be paid to smokers in Quebec whose claim was upheld by the Quebec courts following a class action suit. $2.5 billion will be paid to injured smokers in other parts of Canada, even though there were no lawsuits resolved for these cases.  Up to $100,000 will be paid to each Quebec victim, and up to $60,000 to each victim in other parts of Canada. Money for these payments will be made available soon after the agreement is approved by court.

* $1 billion will be used to establish a foundation focused on activities to support victims who do not direct compensation. $131 million from the Quebec Class Action will be directed to this fund. These payments will not be deferred.

* Lesser amounts to additional claimants (tobacco farmers, the "Knight" class action", etc). 

Not included in the plan

This agreement contains no admission of liability on the part of the companies. Nor does it include any concessions or undertakings by the industry with respect to the way they market tobacco, nicotine or other products. 

The next steps

Because this settlement is being negotiated through Canada's insolvency laws, the settlement is not final until the provincial government, class action and other "creditors" of the three companies vote to approve it. That vote is scheduled for December 12, 2024.  Court hearings to formally approve the agreement would be held at a later date.

A claims procedure has been established for injured Quebec smokers, who can submit their claim through the following portal: www.recourstabac.com

Financial Context:

Over the period of these lawsuits:

Thursday 3 October 2024

Mistakes happen

The bad news is that the data from the Canadian Community Health Survey released by Statistics Canada earlier this week were incorrect. The good news is that the growth in vaping rates is lower than indicated by the data published on Wednesday.

Statistics Canada reached out earlier today to inform us that "the numbers cited in your message have actually been revised for the 2022 reference period. When we published yesterday, we had not known that there was an error in the coding of the indicator for past 30 day vaping/e-cigarette use. ... we have released the corrected numbers for 2022 (Health indicator statistics, annual estimates (statcan.gc.ca)), which show 1.7 million vapers or 5.7% of the adult population, rather than the numbers we had mistakenly published yesterday (1.3 million/4.8%)."

The corrected figures are shown below:






The growth in the vaping population as measured by this survey between 2022 and 2023 was thus 168,700. We still do not know whether these individuals are people who used vaping to quit smoking, or whether vaping products are their introduction to nicotine use, or whether they both smoke and vape. Such tabulations are not difficult, but they require access to the data files (not currently available to non-University-based researchers).

Information on smoking status was readily available to the public when the Canadian Tobacco and Nicotine Survey was in the field from late 2019 to early 2013. The last wave of that now-defunct survey found 240,100 more vapers in 2022-23 than in 2021-22. Of those, 206,900 (86%) were never smokers. 




Thursday 5 September 2024

Health Canada needs a new legislated purpose for tobacco

This post discusses the increasing importance of amending the Tobacco and Vaping Products Act to give Health Canada a broader scope for action and clearer instructions from Parliament. This reflection is prompted by two actions recently taken by Health Canada.

The first of these was the release of the department's proposed framework for cost recovery from tobacco companies.  As reported here earlier, the department's capacity to apply the polluter pay principle to this industry is severely limited by the narrowly-constructed purpose of the current law. Only those costs which are linked to the legislative objectives of the Tobacco and Vaping Products Act (TVPA) can be claimed from the industry.

The second action was the Ministerial Order made public and formally published in August which set specific rules for the marketing and distribution of nicotine pouches regulated under the Food and Drugs Act (FDA). The order is a reminder that as tobacco companies morph into other product categories, health authorities need flexible and wrap-around powers to manage this transformation. The 'belt' of this Ministerial Order would be more secure if the department had the 'suspenders' of integrating the use of these products in its tobacco strategy.

The TVPA's purpose is well past its best before date

The TVPA's purpose was conceived in the 1980s and reflects the priorities and limitations of that era. Despite two major legislative overhauls, the intent and purpose of the federal tobacco law has not substantially changed in almost 40 years. 

The evolution in the purpose of the Tobacco Products Control Act (1988), the Tobacco Act (1997) and the Tobacco and Vaping Products Act (2018) is shown below and can be downloaded here. The articulated purpose is limited to (a) preventing people from starting to use vaping or tobacco products and (b) providing information and countering disinformation on health risks of vaping or using tobacco products. 

The tobacco industry has gone through substantial re-invention since that mandate was conceptualized, and Canadian support for stronger laws has steadily grown. Nonetheless, Parliament has not returned to its vision of how to manage tobacco and has yet to give Health Canada stronger powers and clearer directions on how to manage the problems caused by this industry. 

The current law does not authorize Health Canada to adopt strategies to end tobacco use -- or even to promote smoking cessation. It sets no goals to reduce the number of people who smoke, or to reduce the injuries caused by these products. The vagueness of this legislated mandate is reflected in the minimalist documentation for "Canada's Tobacco Strategy". The narrowness of the legislative mandate means that Health Canada will have difficulty demanding that the industry pay for many of the costs that it causes.


Parliament has given Health Canada clear instructions in other laws

The Canadian Environmental Protection Act (CEPA) provides an example of an expanded and robust legislative purpose, and is a model for how the TVPA could re-invigorate the federal strategy. Like the tobacco law, CEPA was first passed by Parliament in 1988. It however, has been the subject of more detailed Parliamentary study. Parliament's instructions to CEPA are outlined in 3 mutually-reinforcing sections:

1) DECLARATION. A 35-word legislative objective that gives the law broad application: "It is hereby declared that the protection of the environment is essential to the well-being of Canadians and that the primary purpose of this Act is to contribute to sustainable development through pollution prevention."

2) PREAMBLE. An 800 word expansion of the values behind the law, with 24 clauses outlining specific values.

3) DIRECTION. CEPA gives a dozen or more specific instructions to the federal government in how the law should be administered. Examples of these obligations include a mandate to ... "apply the precautionary principle ....", "protect the right of every individual in Canada to a healthy environment...", "take the necessity of protecting the environment into account in making social and economic decisions."

The CEPA approach can be adapted for tobacco control

Adapting the CEPA approach to modify the federal tobacco law would provide a number of benefits and could help:

  • clarify the goals that should guide Health Canada's strategy
  • expand the scope of activities that can be charged to the tobacco and nicotine industry
  • provide instructions, guidance and support to health ministers in managing this long-standing health problem
  • authorize the department to engage in activities to discourage the use of nicotine products other than tobacco- and vaping products.
  • provide the public with transparency about the mandate of Health Canada
An example of a revised purpose section is shown below (and can be downloaded here). This text adds only 200 more words to the law, but greatly expands and clarifies Health Canada's responsibilities. 

In this example, the core purpose of the federal tobacco law is simply stated: "The primary purpose of this Act is to contribute to the elimination of the harms to human and environmental health caused by commercial tobacco and nicotine products."

The suggested text instructs Health Canada on key aspects of addressing the harms caused by the tobacco industry. These include: 

  • Developing a nicotine reduction strategy with measurable objectives 
  • Fully implementing the Framework Convention on Tobacco Control
  • Respecting and supporting traditional non-commercial tobacco use in First Nations
  • Adopting measures to protect the environment with respect to tobacco and nicotine products
  • Reducing health disparities with respect to the use of tobacco and nicotine products
  • Appling the precautionary principle.

Filling a crucial gap

As it is currently written, the TVPA governs tobacco products (those made with tobacco) and vaping products (aerosolized nicotine) but has no power over novel nicotine products. Nicotine pouches are one example of tobacco industry products which are left unaddressed in the law, but there are others on the horizon. 


Over the last year Philip Morris began selling its zero-tobacco LEVIA heat sticks in Czechia, and  Romania and over the past month has launched them in the Netherlands. (They have signalled their intention to market them in Canada by registering the trademark). BAT also sells a tobacco-free heat stick. Both companies also have hybrid products (mixture of vaping and heated tobacco) in development or on the market.

It is not too early to anticipate that these products will be introduced to Canada, whether or not they are legal for sale under federal law. In its public documents (including the Departmental Plan) Health Canada has not made public whether or how it is analyzing the potential benefits or harms of these products being sold in Canada. 

Our organization is among those calling for a fulsome revision and modernization of the federal law, but Health Canada has largely responded to these recommendations by ignoring them. The proposed revisions to the purpose and direction sections would give the department the responsibility and authority to initiate this process.